Pre-excitation syndrome

Revision as of 12:21, 1 September 2020 by Shivam Singla (talk | contribs)
Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4], Associate Editor-In-Chief: Shivam Singla, M.D.[5] Synonyms and keywords: Pre Excitation Syndromes; Pre-Excitation Syndrome; Preexcitation Syndrome; Preexcitation Syndromes

Overview

Pre-excitation syndrome is a condition where ventricles of the heart depolarize earlier than expected via some accessory pathway conduction the normal leading to premature contraction. Normally the atria and the ventricles interconnected through AV node (Atrioventricular node). But in all pre-excitation syndromes, there is present an accessory pathway that conducts impulses to ventricles besides the AV node. The accessory pathway electrical impulses pass to the ventricles before the normal impulse of depolarization through the AV node. The phenomenon of depolarizing ventricles through the accessory pathway earlier than the usual depolarization supposed to happen through the AV node is referred to as "Pre- Excitation". WPW syndrome was described in 1930 and named for the John Parkinson, Paul Dudley White, and Louis Wolff. The accessory pathways are named depending upon the regions of atria and ventricles they are connecting as Bundle of His, Mahaim fibers, James fibers.

The typical ECG findings associated with WPW syndrome are shortened PR interval, widened QRS complex and Delta wave- which is slurring in the upstroke of QRS complex due to preexcitation of ventricles via the accessory pathway. ECG findings along with symptomatic tachyarrhythmias is referred to as Wolff-Parkinson-White syndrome. Although it is more common in the adult males with an incidence rate of 0.1-0.3 %, WPW can be considered as a congenital anomaly in some cases where it is usually present since birth and in others and it is regarded as a developmental anomaly. Studies proved it's lower prevalence in children aged between 6-13 than those in the age group of 14-15 years of age. Hemodynamically unstable patients should be managed on direct cardioversion. For stable patients, medical management should be tried first before going for other acceptable options of catheter ablation or surgical intervention. Although Catheter ablation has widely replaced the surgical option due to less invasive technique and better outcomes still in cases where catheter ablation cannot be done or doesn't prove to be effective the surgical option is worth considering with curative rate of nearly 100%.

Historical Perspective

Classification

Type Conduction pathway QRS interval PR interval Delta wave
Wolff-Parkinson-White syndrome Bundle of Kent Wide/long Usually short yes
Lown-Ganong-Levine syndrome "James bundle" (atria to bundle of His) Normal/Unaffected Short no
Mahaim-type Mahaim fibers long normal


Pathophysiology

Pathophysiology of WPW / Pre-excitation syndrome.[2]

Normally the electrical activity in the heart starts with SA node. The impulse generation usually happens in the right atrium near the entrance of superior vena cava[4]. The impulse from the SA node travels to the AV node. The AV node modulates the rate and number of [impulses]] to be conducted to the ventricles. The AV node also modulates the speed of transmission from atria to ventricles represents the PR interval on ECG. From the AV node, an electrical impulse is transmitted to the bundle of His, to left and right branches extending to the ventricular myocardium.

WPW[5] is another word for pre-excitation of the ventricle through the accessory pathway instead of going through the usual pathway of AV node which usually slows down the speed of conduction of impulses transmitting to ventricles. The accessory pathway creates a channel directly to conduct the impulses to ventricles resulting in premature excitation. In "Type A Pre-excitation" accessory pathway lies between Left atria ventricles and in Type B pre-excitation fibers carry impulses between right atria and ventricles[6][7].

Basic concept of Pathophysiology in pre-excitation syndrome lies in the concept of bypassing the AV node conduction and letting the impulse conduct faster through atria to ventricles via accessory pathways. These accessory pathways Usually called Bundle of Kent in WPW syndrome, James fiber in LGL syndrome and Mahaim fibers in Mahaim type pre-excitation syndrome. These conducts impulses in forward (not common), backward ( around 15-20%) and in both directions ( Most common type) as well.

The accessory pathways mediate the occurrence of tachyarrhythmia by forming a re-entry circuit and commonly known as AVRT. The direct conduction of impulses from atria to ventricles can also result in the development of tachyarrhythmia's when there is a development of Atrial Fibrillation with RVR[8]

WPW syndrome is a combination of WPW pattern on ECG + Paroxysmal arrhythmias. The accessory pathways are usually named as Bundle of Kent or AV bypass tracts. The accessory pathways here are named as James fibers, also known as Atrionodal fibers connecting the atrium to the distal AV node. These usually conduct the impulses from atria to the initial portion of the AV node. The accessory pathways named as Mahaim fibers connect the Atrium, AV node, or bundle of His to the Purkinje fibers or ventricular myocardium.

Differentiating Pre-excitation Syndrome from other Diseases

Arrhythmia Rhythm Rate P wave PR Interval QRS Complex Response to Maneuvers Epidemiology Co-existing Conditions
Atrial Fibrillation[9][10] (AFib)
  • Absent
  • Less than 0.12 seconds, consistent, and normal in morphology in the absence of aberrant conduction
  • 2.7–6.1 million people in the United States have AFib
  • 2% of people younger than age 65 have AFib, while about 9% of people aged 65 years or older have AFib
Atrial Flutter[11]
  • 75 (4:1 block), 100 (3:1 block) and 150 (2:1 block) beats per minute (bpm), but 150 is more common
  • Varies depending upon the magnitude of the block, but is short
  • Less than 0.12 seconds, consistent, and normal in morphology
  • Conduction may vary in response to drugs and maneuvers dropping the rate from 150 to 100 or to 75 bpm
Atrioventricular nodal reentry tachycardia[12][13][14] (AVNRT)''''
  • 140-280 bpm
Multifocal Atrial Tachycardia[15][16]
  • Irregular
  • Atrial rate is > 100 beats per minute
  • Less than 0.12 seconds, consistent, and normal in morphology
Paroxysmal Supraventricular Tachycardia
  • Regular
  • 150 and 240 bpm
  • Absent
  • Hidden in QRS
  • Absent
  • Narrow complexes (< 0.12 s)
Premature Atrial Contractrions (PAC)[17][18]
  • 80-120 bpm
  • Upright
  • Usually narrow (< 0.12 s)
Wolff-Parkinson-White Syndrome[19][20]
  • Regular
  • Atrial rate is nearly 300 bpm and the ventricular rate is at 150 bpm
  • Less than 0.12 seconds
Ventricular Fibrillation[21][22][23] (VF)
  • Irregular
  • 150 to 500 bpm
  • Absent
  • Absent
  • Absent (R on T phenomenon in the setting of ischemia)
Ventricular Tachycardia[24][25]
  • Regular
  • > 100 bpm (150-200 bpm common)
  • Absent
  • Absent
  • Initial R wave in V1, initial r > 40 ms in V1/V2, notched S in V1, initial R in aVR, lead II R wave peak time ≥50 ms, no RS in V1-V6, and atrioventricular dissociation
  • Wide complex, QRS duration > 120 milliseconds
  • 5-10% of patients presenting with AMI

Epidemiology and Demographics

Risk Factors

High-risk population for development of atrial fibrillation or sudden cardiac death include[28]:

Natural History, Complications and Prognosis

Natural History

Complications

Prognosis

Diagnosis

AVRT ( Orthodromic and Antidromic)

WPW Syndrome

Lown-Ganong-Levine(LGL) Syndrome

Mahaim-Type Pre-excitation[32]

  • ECG findings are usually normal

History and Symptoms

People with Pre- Excitation syndromes may be asymptomatic, however, the individuals commonly experience the following symptoms:

Treatment

Medical Treatment

HEMODYNAMICALY UNSTABLE PATIENT -- DIRECT SYNCHRONIZED CARDIOVERSION, BIPHASIC ( INITIAL 100 J, LATER ON- 200J OR 360J).

WPW Treatment Algorithm. Brief flow chart describing the various treatment options that can be selected depending upon the underlying scenario. [https://media.thecardiologyadvisor.com/images/dsm/ch6154.fig11.JPG

]

HEMODYNAMICALLY STABLE PATIENTS -- THE FOLLOWING ALGORITHM CAN BE FOLLOWED

GENERAL PROTOCOL[33]

IN CASE OF ACUTE AVRT/AVNRT

ATRIAL FLUTTER/FIBRILLATION[34]

Catheter Ablation- Surgical Approach in WPW. Image showing catheter ablation of right free wall accessory pathway. The first successful ablation was performed by Morady and Scheinman. [3]

RADIOFREQUENCY ABLATION[26]

Class 3 Antiarrhythmics and class IC drugs are used with AV nodal blocking agents in patients with a history of atrial flutter or A.Fib. Sotalol and Flecainide would be the safe options to use in pregnancy.

Surgical management[35]

Prevention

References

  1. https://doi.org/10.1016/j.eupc.2004.09.005
  2. Lowe KG, Emslie-Smith D, Ward C, Watson H (January 1975). "Classification of ventricular pre-excitation. Vectorcardiographic study". Br Heart J. 37 (1): 9–19. doi:10.1136/hrt.37.1.9. PMC 484149. PMID 1111564.
  3. Kuramoto K, Matsushita S (August 1972). "[Classification and interpretation of WPW syndrome]". Nippon Rinsho (in Japanese). 30 (8): 1770–8. PMID 4561817.
  4. "Wolff-Parkinson-White pattern - Conditions - GTR - NCBI".
  5. "What is the pathophysiology of Wolff-Parkinson-White (WPW) syndrome?".
  6. "American Heart Association | To be a relentless force for a world of longer, healthier lives".
  7. "Wolff-Parkinson-White (WPW) Syndrome ECG Review - Criteria and Examples | LearntheHeart.com".
  8. Moskowitz A, Chen KP, Cooper AZ, Chahin A, Ghassemi MM, Celi LA (October 2017). "Management of Atrial Fibrillation with Rapid Ventricular Response in the Intensive Care Unit: A Secondary Analysis of Electronic Health Record Data". Shock. 48 (4): 436–440. doi:10.1097/SHK.0000000000000869. PMC 5603354. PMID 28328711.
  9. Harris K, Edwards D, Mant J (2012). "How can we best detect atrial fibrillation?". J R Coll Physicians Edinb. 42 Suppl 18: 5–22. doi:10.4997/JRCPE.2012.S02. PMID 22518390.
  10. Lankveld TA, Zeemering S, Crijns HJ, Schotten U (July 2014). "The ECG as a tool to determine atrial fibrillation complexity". Heart. 100 (14): 1077–84. doi:10.1136/heartjnl-2013-305149. PMID 24837984.
  11. Cosío FG (June 2017). "Atrial Flutter, Typical and Atypical: A Review". Arrhythm Electrophysiol Rev. 6 (2): 55–62. doi:10.15420/aer.2017.5.2. PMC 5522718. PMID 28835836.
  12. Letsas KP, Weber R, Siklody CH, Mihas CC, Stockinger J, Blum T, Kalusche D, Arentz T (April 2010). "Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway". Acta Cardiol. 65 (2): 171–6. doi:10.2143/AC.65.2.2047050. PMID 20458824.
  13. Katritsis DG, Josephson ME (August 2016). "Classification, Electrophysiological Features and Therapy of Atrioventricular Nodal Reentrant Tachycardia". Arrhythm Electrophysiol Rev. 5 (2): 130–5. doi:10.15420/AER.2016.18.2. PMC 5013176. PMID 27617092.
  14. Schernthaner C, Danmayr F, Strohmer B (2014). "Coexistence of atrioventricular nodal reentrant tachycardia with other forms of arrhythmias". Med Princ Pract. 23 (6): 543–50. doi:10.1159/000365418. PMC 5586929. PMID 25196716.
  15. Goodacre S, Irons R (March 2002). "ABC of clinical electrocardiography: Atrial arrhythmias". BMJ. 324 (7337): 594–7. doi:10.1136/bmj.324.7337.594. PMC 1122515. PMID 11884328.
  16. Scher DL, Arsura EL (September 1989). "Multifocal atrial tachycardia: mechanisms, clinical correlates, and treatment". Am. Heart J. 118 (3): 574–80. doi:10.1016/0002-8703(89)90275-5. PMID 2570520.
  17. Strasburger JF, Cheulkar B, Wichman HJ (December 2007). "Perinatal arrhythmias: diagnosis and management". Clin Perinatol. 34 (4): 627–52, vii–viii. doi:10.1016/j.clp.2007.10.002. PMC 3310372. PMID 18063110.
  18. Lin CY, Lin YJ, Chen YY, Chang SL, Lo LW, Chao TF, Chung FP, Hu YF, Chong E, Cheng HM, Tuan TC, Liao JN, Chiou CW, Huang JL, Chen SA (August 2015). "Prognostic Significance of Premature Atrial Complexes Burden in Prediction of Long-Term Outcome". J Am Heart Assoc. 4 (9): e002192. doi:10.1161/JAHA.115.002192. PMC 4599506. PMID 26316525.
  19. Rosner MH, Brady WJ, Kefer MP, Martin ML (November 1999). "Electrocardiography in the patient with the Wolff-Parkinson-White syndrome: diagnostic and initial therapeutic issues". Am J Emerg Med. 17 (7): 705–14. doi:10.1016/s0735-6757(99)90167-5. PMID 10597097.
  20. Rao AL, Salerno JC, Asif IM, Drezner JA (July 2014). "Evaluation and management of wolff-Parkinson-white in athletes". Sports Health. 6 (4): 326–32. doi:10.1177/1941738113509059. PMC 4065555. PMID 24982705.
  21. Adabag AS, Luepker RV, Roger VL, Gersh BJ (April 2010). "Sudden cardiac death: epidemiology and risk factors". Nat Rev Cardiol. 7 (4): 216–25. doi:10.1038/nrcardio.2010.3. PMC 5014372. PMID 20142817.
  22. Glinge C, Sattler S, Jabbari R, Tfelt-Hansen J (September 2016). "Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction". J Geriatr Cardiol. 13 (9): 789–797. doi:10.11909/j.issn.1671-5411.2016.09.006. PMC 5122505. PMID 27899944.
  23. Samie FH, Jalife J (May 2001). "Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart". Cardiovasc. Res. 50 (2): 242–50. doi:10.1016/s0008-6363(00)00289-3. PMID 11334828.
  24. Levis JT (2011). "ECG Diagnosis: Monomorphic Ventricular Tachycardia". Perm J. 15 (1): 65. doi:10.7812/tpp/10-130. PMC 3048638. PMID 21505622.
  25. Koplan BA, Stevenson WG (March 2009). "Ventricular tachycardia and sudden cardiac death". Mayo Clin. Proc. 84 (3): 289–97. doi:10.1016/S0025-6196(11)61149-X. PMC 2664600. PMID 19252119.
  26. 26.0 26.1 Cohen MI, Triedman JK, Cannon BC, Davis AM, Drago F, Janousek J, Klein GJ, Law IH, Morady FJ, Paul T, Perry JC, Sanatani S, Tanel RE (June 2012). "PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS)". Heart Rhythm. 9 (6): 1006–24. doi:10.1016/j.hrthm.2012.03.050. PMID 22579340.
  27. http://www.cardiology.sk/casopis/606/pdf/04.pdf
  28. 28.0 28.1 Obeyesekere MN, Leong-Sit P, Massel D, Manlucu J, Modi S, Krahn AD, Skanes AC, Yee R, Gula LJ, Klein GJ (May 2012). "Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: a meta-analysis". Circulation. 125 (19): 2308–15. doi:10.1161/CIRCULATIONAHA.111.055350. PMID 22532593.
  29. https://www.cancertherapyadvisor.com/home/decision-support-in-medicine/hospital-medicine/pre-excitation-syndrome-wpw/
  30. "Wolff-Parkinson-White Syndrome. WPW syndrome info | Patient".
  31. "Wolff-Parkinson-White (WPW) syndrome - Diagnosis and treatment - Mayo Clinic".
  32. Sternick EB, Timmermans C, Sosa E, Cruz FE, Rodriguez LM, Fagundes MA, Gerken LM, Wellens HJ (October 2004). "The electrocardiogram during sinus rhythm and tachycardia in patients with Mahaim fibers: the importance of an "rS" pattern in lead III". J. Am. Coll. Cardiol. 44 (8): 1626–35. doi:10.1016/j.jacc.2004.07.035. PMID 15489095.
  33. Stasiak A, Niewiadomska-Jarosik K, Kędziora P (2018). "Clinical course and treatment of children and adolescents with the preexcitation syndrome - own studies". Dev Period Med. 22 (2): 113–122. PMID 30056397.
  34. Wann LS, Curtis AB, Ellenbogen KA, Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey J, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS (May 2013). "Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines". Circulation. 127 (18): 1916–26. doi:10.1161/CIR.0b013e318290826d. PMID 23545139.
  35. "Surgical treatment of patients with Wolff-Parkinson-White syndrome and associated acquired valvular heart disease - ScienceDirect".